A rising star high school baseball player was about to head off to pitch in college when a sudden, life-threatening condition ...

SL1009 targets a 2025 FDA decision for Pyruvate Dehydrogenase Complex Deficiency (PDCD), while SL1002 advances toward Phase III trials for osteoarthritis knee pain and spasticity ...